Who is the CEO of Anondita Medicare Ltd?
- Answer Field
-
The CEO of Anondita Medicare Ltd is Anupam Ghosh.
BAJAJ BROKING
Anondita Medicare Limited, established in March 2024, operates in the healthcare and wellness sector with a focus on manufacturing flavoured male condoms under its flagship brand “COBRA.” The company runs a production facility in Sector 80, Noida, Uttar Pradesh, with an annual capacity of nearly 562 million condoms, as certified in June 2025. To support sustainable practices, the plant uses CNG as a cleaner fuel option, aligning with environmentally conscious manufacturing processes. As of July 31, 2025, the company had a workforce of 280 employees contributing to its operations and growth.
The company maintains a wide domestic and international presence, supplying to Southeast Asia, Africa, and the Middle East. Its distribution network involves wholesalers, retailers, e-commerce platforms, and strong ties with government health programs, NGOs, and global health organisations. These collaborations enable Anondita Medicare to support family planning initiatives while ensuring accessibility of its products across diverse markets, strengthening its position as it enters the IPO space.
For more details, visit the Anondita Medicare IPO page.
Details | Information |
IPO Date | August 22, 2025 to August 26, 2025 |
Issue Size | 47,93,000 shares (aggregating up to ₹69.50 Cr) |
Price Band | ₹137 to ₹145 per share |
Lot Size | 1000 shares |
Listing At | NSE SME |
Market Maker | Mansi Share & Stock Broking Pvt.Ltd. |
Capital Expenditure
Working Capital Requirement
Unidentified Acquisition and General Corporate Purposes
Event | Date |
---|---|
IPO Open Date | Fri, Aug 22, 2025 |
IPO Close Date | Tue, Aug 26, 2025 |
Tentative Allotment | Thu, Aug 28, 2025 |
Initiation of Refunds | Fri, Aug 29, 2025 |
Credit of Shares to Demat | Fri, Aug 29, 2025 |
Tentative Listing Date | Mon, Sep 1, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on August 26, 2025 |
₹137 to ₹145 per share
Application | Lots | Shares | Amount |
Individual investors (Retail) (Min) | 2 | 2,000 | ₹2,90,000 |
Individual investors (Retail) (Max) | 2 | 2,000 | ₹2,90,000 |
S-HNI (Min) | 3 | 3,000 | ₹4,35,000 |
S-HNI (Max) | 6 | 6,000 | ₹8,70,000 |
B-HNI (Min) | 7 | 7,000 | ₹10,15,000 |
Log in to Your Trading Account: Access your trading account through your broker’s platform.
Navigate to the IPO Section: Go to the IPO section to view active IPO listings.
Select Anondita Medicare IPO: Find "Anondita Medicare IPO" and click on the ‘Apply’ button.
Enter Application Details: Specify the number of lots (minimum lot size: 1000 shares) and the bid price within the range of ₹137 to ₹145 per share.
Provide Your UPI ID: Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.
Review and Submit: Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on August 26, 2025, to complete your application process.
Additional Read- How to Apply for the Anondita Medicare IPO?
Total Assets: Grew from ₹37.80 crore in FY23 to ₹78.27 crore as of March 2025.
Total income: Reached ₹77.13 crore in FY25.
Profit After Tax (PAT): Stood at ₹16.42 crore for March 2025.
Net Worth: Recorded at ₹37.87 crore in FY25.
Reserves and Surplus: Recorded at ₹24.58 crore (March 2025), growing steadily over the years.
EBITDA: Stood at ₹25.65 crore in March 2025.
The company has consistently expanded its asset base over the recent financial years, indicating stability and growth in operations.
Its income levels have shown a steady upward movement, reflecting increasing business activity.
Profitability has remained positive, highlighting the company’s ability to manage costs effectively and generate returns.
The organisation has strengthened its net worth, which points towards a solid financial position.
Reserves and surplus have continued to grow, demonstrating healthy retention of earnings for future expansion.
Operational performance has improved, with earnings before interest, taxes, depreciation, and amortisation showing a strong upward trend.
The company’s business is concentrated in the condom manufacturing segment, making it sensitive to changes in demand, competition, and regulatory guidelines in the healthcare and wellness industry.
Expansion into multiple international markets exposes the business to risks such as currency fluctuations, trade regulations, and reliance on global health initiatives.
A wide domestic and international distribution network, along with collaborations with NGOs and government programmes, positions the company to capture growing demand for family planning and wellness products.
Focus on sustainable production methods, increasing brand presence, and strong institutional partnerships provide a platform for long-term growth and diversification.
KPI | Values |
ROE | 41.71% |
ROCE | 37.42% |
Debt/Equity | 0.70 |
RoNW | 41.71% |
PAT Margin | 21.32% |
EBITDA Margin | 33.32% |
Price to Book Value | 15.07 |
Registrar | Lead Manager(s) |
---|---|
Maashitla Securities Pvt.Ltd. | Narnolia Financial Services Ltd. |
Anondita Medicare Ltd. Flat No.704 Narmada Block, N6, Sec-D, Pkt-6 Vasant Kunj, New Delhi, New Delhi, 110070
Phone: 0120-4520300
Email: info@anonditamedicare.com
Website: https://anonditamedicare.com/
Anondita Medicare Limited operates in the healthcare and wellness sector with a focus on male condom manufacturing under its brand “COBRA.” The company has established its production base in Noida, supported by sustainable fuel practices and a workforce contributing to its operations. Its presence spans both domestic and international markets through collaborations with wholesalers, e-commerce platforms, NGOs, and government programmes.
The upcoming IPO has been structured to meet capital expenditure needs, working capital requirements, and other general purposes. Investors can review the objectives, pricing, and application process to understand how the offering aligns with the company’s ongoing business activities and expansion plans.
Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Anondita Medicare IPO.
Share this article:
No result found
The CEO of Anondita Medicare Ltd is Anupam Ghosh.
The IPO will open on August 22, 2025, and close on August 26, 2025.
Anondita Medicare Limited manufactures flavoured male condoms under its flagship brand “COBRA.” It supplies products to domestic and international markets, working with NGOs, global health organisations, and government health programmes. The company has also adopted cleaner fuel practices in its production process. Its business model depends on demand for healthcare and wellness products, regulatory compliance, and international partnerships.
The IPO consists of 47,93,000 shares, aggregating up to ₹69.50 crore.
‘Pre-apply’ allows investors to place IPO applications before the subscription period begins. Once the IPO opens, these applications are submitted automatically.
Investors will receive a confirmation notification from the exchange or broker platform after submitting their application and approving the UPI mandate.
The minimum lot size is 1,000 shares, and retail investors must apply for at least 2 lots (2,000 shares).
The tentative allotment date is August 28, 2025.
The registrar of the IPO is Maashitla Securities Pvt. Ltd.
No publicly available information indicates governance issues or red flags in the leadership or board structure of Anondita Medicare Ltd as of now.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading